Tofflon (300171): Won the procurement project of Liaoning Qingyang Special Chemical Co., Ltd., with a bid amount of 5.75 million yuan同壁财经·May 20 at 05:46 AM300171+0.66%
Tofflon released its performance for the first three quarters, with a net profit attributable to the parent company of 132 million yuan, a decrease of 13.86%Zhitong·Oct 28, 2025 at 04:14 AM300171+0.66%
Tofflon and others established a biotechnology company with a registered capital of 100 million yuanZhitong·Sep 15, 2025 at 10:33 PM300171+0.66%
Tofflon released its performance for the first half of the year, with a net profit attributable to the parent company of 45.9195 million yuan, a decrease of 59.71%Zhitong·Aug 27, 2025 at 08:05 AM300171+0.66%
Tofflon and THDB signed a strategic cooperation agreementZhitong·Jun 30, 2025 at 07:46 PM600867+0.36%300171+0.66%
Tofflon: Net profit of 194 million yuan in 2024, a year-on-year decrease of 67.66%Zhitong·Apr 24, 2025 at 07:58 AM300171+0.66%
The medical equipment sector saw a short-term surge, with VISHEE rising over 10%Zhitong·Apr 1, 2025 at 09:43 PM300171+0.66%688580+4.02%
Shanghai Biomedical M&A Private Equity Fund Established with a Capital Contribution of 4.66 Billion YuanZhitong·Mar 26, 2025 at 09:41 PM688180+2.15%01877+0.22%
Tofflon Science and Technology Group Co., Ltd.'s (SZSE:300171) Share Price Is Matching Sentiment Around Its RevenuesSimplywall·Feb 28, 2025 at 07:31 PM300171+0.66%
Tofflon plans to invest 200 million yuan to participate in the establishment of the Shanghai Biopharmaceutical M&A FundZhitong·Jan 27, 2025 at 02:04 AM300171+0.66%
Tofflon issued a profit warning, expecting a net profit of 185 million to 235 million yuan for the year 2024, a year-on-year decrease of 60.85% to 69.18%Zhitong·Jan 24, 2025 at 02:41 AM300171+0.66%
